HAMP and metabolic dysfunction-associated steatohepatitis: Berki and colleagues have shown that obese patients or those with diabetes or nonalcoholic steatohepatitis showed reduced hepatic hepcidin expression and increased adipose hepcidin expression compared to lean controls [16], which suggests that serum hepcidin is derived from not only the liver but also from other tissues including adipose.